Contaminated valsartan does not increase short-term risk of cancer, study finds

04:36 EDT 14 Sep 2018 | The Pharmaceutical Journal

Valsartan contaminated with the impurity N-nitrosodimethylamine (NDMA) does not increase the short-term risk of overall cancer, according to research published in The BMJ.

More From BioPortfolio on "Contaminated valsartan does not increase short-term risk of cancer, study finds"